NCT05506631

Brief Summary

The objective of this study is to determine the impact of outpatient cervical ripening with transcervical balloon placement for induction of labor at term on the length and cost of inpatient hospitalization when compared to inpatient cervical ripening.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 8, 2021

Completed
8 months until next milestone

First Posted

Study publicly available on registry

August 18, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

2.6 years

First QC Date

December 8, 2021

Last Update Submit

May 27, 2025

Conditions

Keywords

cervical RipeningLabor, inducedTerm Birth

Outcome Measures

Primary Outcomes (2)

  • The length of time (measured in minutes) spent on the inpatient unit from admission from cervical ripening and/or labor induction until delivery.

    The length of time (measured in minutes) spent on the inpatient unit (L\&D) from admission for cervical ripening and/or labor induction until delivery.

    12 months

  • Cost Analysis in dollars Cost/charges will be calculated for the time spent in the outpatient and inpatient unit for both randomization groups.

    Cost Analysis in dollars Cost/charges will be calculated for the time spent in the outpatient and inpatient unit for both randomization groups. Cost will be based on information obtained from Enterprise Analytics charges for the time each woman spends in outpatient care, inpatient care, hospitalized from admission to the L\&D unit to delivery.

    12 months

Secondary Outcomes (12)

  • Delivery

    12 months

  • Maternal state

    12 months

  • Neonatal State

    12 months

  • Maternal Adverse events

    12 months

  • Neonatal adverse events

    12 months

  • +7 more secondary outcomes

Study Arms (2)

Outpatient cervical ripening

EXPERIMENTAL

Placement of transcervical Foley balloon for cervical ripening in outpatient setting

Procedure: Outpatient Foley balloon placement

Inpatient cervical ripening

ACTIVE COMPARATOR

Placement of transcervical Foley balloon for cervical ripening in inpatient setting

Procedure: Inpatient Foley Balloon placement

Interventions

Cervical ripening with balloon placement in the outpatient setting

Outpatient cervical ripening

Cervical ripening with balloon placement in the inpatient setting

Inpatient cervical ripening

Eligibility Criteria

Age18 Years - 39 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women at ≥39 weeks gestation by reliable dating criteria as determined by the American College of Obstetricians and Gynecologists
  • Scheduled induction of labor with indication and timing supported by Lehigh Valley Health Network -Labor and Delivery Units (Cedar Crest \& Muhlenberg)
  • Singleton gestation
  • Cephalic presentation
  • Amniotic fluid index normal
  • Formal prenatal ultrasound during the pregnancy documenting the absence of placenta previa
  • Bishop score \<6 and cervical dilation \<3cm at the time of decision to induce labor
  • The woman is able to give appropriate consent and has undergone an informed consent process.
  • Maternal age ≥ 18 years old at the time of consent
  • English speaking

You may not qualify if:

  • Undergoing outpatient antenatal testing for any medical or obstetric condition
  • Need for inpatient observation or continuous fetal monitoring during their cervical ripening
  • New diagnosis requiring immediate hospitalization for monitoring (such as new onset hypertensive disease of pregnancy)
  • Vaginal bleeding
  • Active labor
  • Premature rupture of membranes
  • Uterine tachysystole (\>5 contractions in 10 minutes)
  • Non-reassuring fetal heart tracing before Foley placement
  • Intrauterine fetal demise diagnosed after enrollment and before placement of balloon
  • Contraindication to vaginal delivery, relative or absolute (i.e. transfundal uterine surgery)
  • Abnormal placentation including a low lying placenta
  • Prior cesarean delivery
  • Known fetal major anomaly
  • Human immunodeficiency virus, Hepatitis C, or active herpes infection
  • Maternal cardiopulmonary disease requiring cardiac monitoring during labor
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lehigh Valley Health Network

Allentown, Pennsylvania, 18105, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice Chair Research, Dept OBGYN, Lehigh Valley Health Network

Study Record Dates

First Submitted

December 8, 2021

First Posted

August 18, 2022

Study Start

November 1, 2021

Primary Completion

May 30, 2024

Study Completion

October 30, 2024

Last Updated

May 31, 2025

Record last verified: 2025-05

Locations